Skip to main content

Advertisement

SpringerLink
Log in

Radiation therapy in indolent primary cutaneous B cell lymphoma: a single institute experience

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

To report the clinical results after definitive radiotherapy (RT) for indolent primary cutaneous B cell lymphoma (pcBCL). The data concerning all patients treated for indolent pcBCL with RT with a curative intent between 1992 and 2012 were reviewed. All cases were (re)classified according to the World Health Organization (WHO) guidelines. A total of 42 patients with biopsy-proven primary cutaneous follicle center lymphoma (pcFCL) and primary cutaneous marginal zone lymphoma (pcMZL) were included. The median follow-up is 9.5 years. Treatment with RT resulted in complete response (CR) in all patients. Eight patients showed one or multiple relapses confined to the skin. No in-field recurrences were observed. For the entire cohort, the 10-year relapse-free survival (RFS) and overall survival (OS) were 71.1% and 87.1%, respectively. Univariate (UA) and multivariate (MA) analysis revealed extra-trunk primary lesion (MA) and multiple lesions (UA) as unfavorable prognostic factors. The 5-year RFS rate for patients with trunk lesion was 89.4% versus 66.9% for those with other location (p = 0.02). The 5-year RFS rates were 83.5 and 57.1% in case of single and multiple lesions (p = 0.04). An excellent survival can be achieved with definitive RT in indolent pcBCL. Patients with multiple and extra-trunk primary cutaneous lesions probably warrants intensification of therapy. Prospective studies are mandatory.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Bradford PT, Devesa SS, Anderson WF, Toro JR (2009) Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood 113(21):5064–5073

    Article  CAS  Google Scholar 

  2. Swerdlow SH, Campo E, Harris NL, Jaffa ES, Pileri SA, Stein H, Thiele J (eds) (2017) WHO classification of tumours of haematopoietic and lymphoid tissues (revised 4th edition). lARC, Lyon

    Google Scholar 

  3. Suárez AL, Pulitzer M, Horwitz S, Moskowitz A, Querfeld C, Myskowski PL (2013) Primary cutaneous B-cell lymphomas: part I. Clinical features, diagnosis, and classification. J Am Acad Dermatol 69(3):329.e1–13

    Article  Google Scholar 

  4. National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Primary cutaneous B-cell lymphomas, version 2.2018. Available at: http://www.nccn.org. Accessed 1 Feb 2018

  5. Hallermann C, Niermann C, Fischer RJ, Schulze HJ (2011) Survival data for 299 patients with primary cutaneous lymphomas: a monocentre study. Acta Derm Venereol 91(5):521–525

    Article  Google Scholar 

  6. Hamilton SN, Wai ES, Tan K, Alexander C, Gascoyne RD, Connors JM (2013) Treatment and outcomes in patients with primary cutaneous B-cell lymphoma: the BC Cancer Agency experience. Int J Radiat Oncol Biol Phys 87(4):719–725

    Article  Google Scholar 

  7. Mian M, Marcheselli L, Luminari S, Federico M, Cantonetti M, Sarris AH, Rossi A, Rambaldi A, Frontani M, Devizzi L, Gianni AM, Busetto M, Berti E, Martinelli G, Tsang RW, Ferreri AJ, Pinotti G, Pogliani E, Zucca E, Cortelazzo S (2011) CLIPI: a new prognostic index for indolent cutaneous B cell lymphoma proposed by the International Extranodal Lymphoma Study Group (IELSG 11). Ann Hematol 90(4):401–408

    Article  Google Scholar 

  8. Senff NJ, Hoefnagel JJ, Neelis KJ, Vermeer MH, Noordijk EM, Willemze R, Dutch Cutaneous Lymphoma Group (2007) Results of radiotherapy in 153 primary cutaneous B-cell lymphomas classified according to the WHO-EORTC classification. Arch Dermatol 143(12):1520–1526

    Article  Google Scholar 

  9. Zinzani PL, Quaglino P, Pimpinelli N, Berti E, Baliva G, Rupoli S, Martelli M, Alaibac M, Borroni G, Chimenti S, Alterini R, Alinari L, Fierro MT, Cappello N, Pileri A, Soligo D, Paulli M, Pileri S, Santucci M, Bernengo MG, Italian Study Group for Cutaneous Lymphomas (2006) Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. J Clin Oncol 24(9):1376–1382

    Article  Google Scholar 

  10. Haverkos B, Tyler K, Gru AA, Winardi FK, Frederickson J, Hastings J, Elkins C, Zhang X, Xu-Welliver M, Wong HK, Porcu P (2015) Primary cutaneous B-cell lymphoma: management and patterns of recurrence at the Multimodality Cutaneous Lymphoma Clinic of The Ohio State University. Oncologist 20(10):1161–1166

    Article  CAS  Google Scholar 

  11. Khamaysi Z, Ben-Arieh Y, Izhak OB, Epelbaum R, Dann EJ, Bergman R (2008) The applicability of the new WHO-EORTC classification of primary cutaneous lymphomas to a single referral center. Am J Dermatopathol 30(1):37–44

    Article  Google Scholar 

  12. Kim MJ, Hong ME, Maeng CH, Jung HA, Hong JY, Choi MK, Kim SJ, Ko YH, Kim WS (2015) Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South Korea. Int J Hematol 101(3):273–278

    Article  Google Scholar 

  13. Lee WJ, Lee SH, Moon IJ, Won CH, Chang SE, Choi JH, Park CS, Suh C, Lee MW (2016) Relative frequency, clinical features, and survival outcomes of 395 patients with cutaneous lymphoma in Korea: a subgroup analysis per 10-year period. Acta Derm Venereol 96(7):888–893

    Article  Google Scholar 

  14. Lucioni M, Berti E, Arcaini L, Croci GA, Maffi A, Klersy C, Goteri G, Tomasini C, Quaglino P, Riboni R, Arra M, Dallera E, Grandi V, Alaibac M, Ramponi A, Rattotti S, Cabras MG, Franceschetti S, Fraternali-Orcioni G, Zerbinati N, Onida F, Ascani S, Fierro MT, Rupoli S, Gambacorta M, Zinzani PL, Pimpinelli N, Santucci M, Paulli M (2016) Primary cutaneous B-cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: comparison with current classification and definition of prognostic markers. Cancer Med 5(10):2740–2755

    Article  CAS  Google Scholar 

  15. Nudelmann LM, Bonamigo RR (2015) Primary cutaneous lymphoma in southern Brazil: a 12-year single-center experience. Int J Dermatol 54(12):e512–e520

    Article  CAS  Google Scholar 

  16. Cancer Therapy Evaluation Program. Common terminology criteria for adverse events, version 4.0 2009, Available at: http://ctep.cancer.gov. Accessed 1 Feb 2018

  17. Cheson BD (2015) Staging and response assessment in lymphomas: the new Lugano classification. Chin Clin Oncol 4(1):5

    Google Scholar 

  18. Schemper M, Smith TL (1996) A note on quantifying follow-up in studies of failure time. Control Clin Trials 17(4):343–346

    Article  CAS  Google Scholar 

  19. Kim YH, Willemze R, Ni P, for the ISCL and the EORTC et al (2007) TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 110:479–484

    Article  CAS  Google Scholar 

  20. Goodlad JR, Krajewski AS, Batstone PJ, McKay P, White JM, Benton EC, Kavanagh GM, Lucraft HH (2003) Scotland and Newcastle Lymphoma Group. Primary cutaneous diffuse large B-cell lymphoma: prognostic significance of clinicopathological subtypes. Am J Surg Pathol 27(12):1538–1545

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiotherapy, Policlinico Umberto I “Sapienza” University of Rome, Viale Regina Elena 326, 00161, Rome, Italy

    Francesca De Felice, Lavinia Grapulin, Alessandra Pieroni, Francesca Salerno, Daniela Musio & Vincenzo Tombolini

  2. Department of Cellular Biotechnologies and Hematology, Policlinico Umberto I “Sapienza” University of Rome, Viale Regina Elena 326, 00161, Rome, Italy

    Gianna Maria D’Elia & Alessandro Pulsoni

Authors
  1. Francesca De Felice
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lavinia Grapulin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alessandra Pieroni
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Francesca Salerno
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gianna Maria D’Elia
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Alessandro Pulsoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Daniela Musio
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Vincenzo Tombolini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Francesca De Felice.

Ethics declarations

Conflict of interest

Author Francesca De Felice declares that she has no conflict of interest. Author Lavinia Grapulin declares that she has no conflict of interest. Author Alessandra Pieroni declares that she has no conflict of interest. Author Francesca Salerno declares that she has no conflict of interest. Author Gianna Maria D’Elia declares that she has no conflict of interest. Author Alessandro Pulsoni declares that he has no conflict of interest. Author Daniela Musio declares that she has no conflict of interest. Author Vincenzo Tombolini declares that he has no conflict of interest.

Ethical approval

All procedures performed were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

De Felice, F., Grapulin, L., Pieroni, A. et al. Radiation therapy in indolent primary cutaneous B cell lymphoma: a single institute experience. Ann Hematol 97, 2411–2416 (2018). https://doi.org/10.1007/s00277-018-3471-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-018-3471-x

Keywords

Search

Navigation